The success of NHS England's Innovative Medicines Fund will depend on its operational details
Nat Med
.
2023 Feb;29(2):289-291.
doi: 10.1038/s41591-023-02206-w.
Authors
Aris Angelis
1
2
,
Ajay Aggarwal
3
4
,
Andrew Briggs
3
Affiliations
1
Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK. Aris.Angelis@lshtm.ac.uk.
2
Department of Health Policy and LSE Health, London School of Economics and Political Science, London, UK. Aris.Angelis@lshtm.ac.uk.
3
Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
4
Department of Oncology, Guy's & St Thomas' NHS Trust, London, UK.
PMID:
36782030
DOI:
10.1038/s41591-023-02206-w
No abstract available
Publication types
Letter
MeSH terms
England
Financial Management*
Health Care Reform
State Medicine*